Literature DB >> 2066959

Methotrexate treatment of multicentric reticulohistiocytosis.

O Gourmelen1, X Le Loët, M Fortier-Beaulieu, E Thomine, G Ledan, P Lauret, P Deshayes.   

Abstract

We describe a 68-year-old woman with multicentric reticulohistiocytosis. The patient's symptoms responded well to methotrexate 7.5 and then 10 mg/week orally. After 34 months of treatment, her disease was still in remission.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2066959

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

Review 1.  Multicentric reticulohistiocytosis: a critical review.

Authors:  Carlo Selmi; Adam Greenspan; Arthur Huntley; M Eric Gershwin
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

Review 2.  Multicentric reticulohistiocytosis: a rare yet challenging disease.

Authors:  Arshia D Islam; Stanley M Naguwa; Gurtej S Cheema; John C Hunter; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 3.  Multicentric reticulohistiocytosis: case report with response to infliximab and review of treatment options.

Authors:  Cristina C Macía-Villa; Antonio Zea-Mendoza
Journal:  Clin Rheumatol       Date:  2014-04-15       Impact factor: 2.980

4.  Multicentric reticulohistiocytosis.

Authors:  H Kocanaogullari; H Ozsan; F Oksel; G Ozturk; G Kandiloglu; E E Ustun; E Doganavsargil
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.